CSI Market
Sign In | Register

Briacell Therapeutics (BCTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access BCTX quarterly Balance Sheets →
The data below summarizes Briacell Therapeutics's balance sheet position from Jul 31 2021 to Jul 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jul 31 2025)
(Jul 31 2024) (Jul 31 2023) (Jul 31 2022) (Jul 31 2021)
Assets
Cash & cash equivalent10.49
Cash, Cash Equivalents Other0.00
Short-term Investments, Total7.37
Cash & Short-term Investments17.00
Accounts receivable0.00
Trade & Other Current Receivables (IFRS combined total)-
Derivatives, Collateral, Regulatory, Deferred0.00
Other Current Assets2.06
Prepaid Expense, Current AS0.10
Total Current Assets19.93
Equipment/Property/Plant Net0.30
Intangible Assets0.18
Long-term investments0.00
Tax Assets, Noncurrent28.43
Prepaid Expense, Noncurrent, Total PR0.72
Other Assets, Noncurrent0.00
Accounts Receivable And Prepaid Expenses Current2.06
Equity Securities F V N I Noncurrent0.52
Total Assets21.65
Liabilities
Accounts Payable0.69
Accrued Liabilities, Current0.00
Other Liabilities, Current3.28
Total Current Liabilities3.98
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.34
Accrued Income Taxes, Noncurrent4.10
Warrant Liability Noncurrent-
Total Liabilities8.42
Stockholders' Equity
Warrant Reserve17.72
Sharebased Payment Reserve10.32
Common Stock Value101.74
Additional Paid In Capital Common Stock0.00
Retained Earnings / Accumulated Deficit-111.76
Accumulated Other Comprehensive Income-0.14
Other Equity-0.14
Common Stockholder's Equity17.88
Non-controlling interests & other-0.55
Total Stockholder's Equity17.33
Liabilities & Stockholder's Equity21.65
4 historic quarters locked

Sign in to unlock the full Briacell Therapeutics balance sheet history.

Sign In Create Free Account

About Briacell Therapeutics Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20250731)
  • Filed with the SEC: October 15, 2025
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-25-018212

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License